Condition
Metastatic Osteosarcoma clinical trials and research
Research outlook What's coming for Osteosarcoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Metastatic Osteosarcoma clinical trials that are recruiting, at sites in 6 countries (most in United States (2), Australia (1), Canada (1)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Comparing two surgical methods for lung cancer in osteosarcoma patients
This study is testing whether open chest surgery or a less invasive approach is better for helping osteosarcoma patients with lung cancer live longer and feel less pain after surgery.
-
Combining atezolizumab and cabozantinib for treating recurrent or metastatic osteosarcoma in adolescents and young adults
This study tests if combining two medications, atezolizumab and cabozantinib, can help adolescents and young adults with recurrent or metastatic osteosarcoma live longer and feel better.
Related topics
Quick answers
How many Metastatic Osteosarcoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (2 trials), Australia (1 trial), Canada (1 trial), New Zealand (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.